Huarong Bio-B (02396.HK) will be listed for public offering from December 12th to December 17th, and plans to globally issue 17.6488 million H shares, expected to be listed on December 22nd.

Wise Financial News APP, Huarun Biotech-B (02396.HK) is scheduled to go public from December 12, 2025 to December 17, 2025. The company plans to globally offer 17.6488 million H shares, with approximately 10% for public offering in Hong Kong and about 90% for international offering, with an additional 15% over-allotment option. The offering price per share is between 38.2 and 51 Hong Kong dollars. Each lot consists of 200 H shares, with trading of H shares expected to commence at 9:00 AM on December 22, 2025 on the Hong Kong Stock Exchange.